Peter Greenleaf

Insider Reports History

Location
Edmonton
Signature
/s/ Francis Knuettel II, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Greenleaf:

Form 4 holding Chief Executive Officer, Director

Aurinia Pharmaceuticals Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
328,424
Estimated value
Report date
27 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ANTARES PHARMA, INC.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
24 May 2022
Price
$5.60
Ownership
Direct
Form 4 holding Director

ANTARES PHARMA, INC.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
24 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Peter Greenleaf

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .